Cargando…
CAPER as a therapeutic target for triple negative breast cancer
Breast cancers (BCas) that lack expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are referred to as triple negative breast cancers (TNBCs) and have the poorest clinical outcome. Once these aggressive tumors progress to distant...
Autores principales: | Campbell, Mallory C., Pontiggia, Laura, Russell, Ashley Y., Schwarting, Roland, Camacho, Jeanette, Jasmin, Jean-Francois, Mercier, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084388/ https://www.ncbi.nlm.nih.gov/pubmed/30100993 http://dx.doi.org/10.18632/oncotarget.25719 |
Ejemplares similares
-
Development of CAPER peptides for the treatment of triple negative breast cancer
por: Chilewski, Shannon D., et al.
Publicado: (2020) -
Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer
por: Dees, Sundee, et al.
Publicado: (2020) -
Influence of Seed-Covering Layers on Caper Seed Germination
por: Foschi, María Laura, et al.
Publicado: (2023) -
Venezuelan Equine Encephalitis Virus Capsid—The Clever Caper
por: Lundberg, Lindsay, et al.
Publicado: (2017) -
Effects of High Intensity Ultrasound Stimulation on the Germination Performance of Caper Seeds
por: Foschi, María Laura, et al.
Publicado: (2023)